LifeMark Partners Offers Cancer Genomic Profiling Program

BALTIMORE, January 15, 2018— LifeMark Partners, Inc., one of the nation's largest independent national insurance marketing organizations, today announced that a complimentary cancer genomic profiling program will be exclusively available to its partner BGAs. This first of its kind offer, will allow BGAs affiliated with LifeMark Partners to initially provide 250,000 Americans, who purchased new life insurance policies, with instant complimentary access for one year to Wamberg Genomic Advisors’ Cancer Guardian program. Cancer Guardian is for the sequencing of a cancer tumor to learn about coding mutations that contribute to tumor progression.

In addition, the Cancer Guardian program will be offered at a discount to 2,000,000 existing policyholders who have purchased life insurance through LifeMark and its affiliated BGAs.

“It is truly an honor for us to be the first insurance marketing organization to offer this type of advanced program to our partner BGAs. This progressive program is a vital tool that will allow our partners to help clients of their advisors, producers and agents should they suffer the unfortunate diagnosis of cancer,” said William Shelow, CLU^®, ChFC^®, CPCU^®, LLIF, president and chief executive officer, LifeMark Partners. “As our partners have come to expect, this is another innovative step we take in order to provide the most advanced tools and technology to our BGAs so they in turn have the most up-to-date services for the clients of their advisors, producers and agents.”

The information provided by Wamberg Genomic Advisors Cancer Guardian program can be used to increase the accuracy of the diagnosis and highlight more effective and appropriate treatment options, including clinical trials, based on the genetic profile of an individual’s cancer. The 2017 MOSCATO trial showed that half of cancers have actionable genetic mutations that are potentially treatable with targeted cancer drugs that currently exist (1). When obtaining these comprehensive genomic tests outside of Wamberg Genomic Advisors’ innovative program, the price is in excess of $7,000 and are not covered by health insurance in most cases.

"What LifeMark is doing is unprecedented and invaluable. An individual’s cancer genomic profile, first and foremost, can be instrumental in helping patients beat cancer by helping physicians create powerful, personalized care paths,” said Tom Wamberg, president & CEO of Wamberg Genomic Advisors. “LifeMark and its BGAs are also part of a much greater societal good. As more people with cancer receive comprehensive genomic profiling tests, the more scientific data we have to move towards a cure for cancer.”

Underwriters Brokerage Service, an independent life and health brokerage agency located in Pittsburgh, PA is a LifeMark Partner agency. Its president Mark Rosen, CLU, also serves as chairman of LifeMark, said, “This gives our BGA, and all LifeMark’s affiliated BGAs, an incredible new product. But, more importantly, we can truly help clients of our advisors, producers and agents.”

The Cancer Guardian program is complimentary for one year when offered to new policy holders of an advisor, producer and agent who works through a LifeMark Partner Agency to meet their insurance needs. The program is then priced at less than $20 per month from that point on - family members can also be included in this program. The program officially launches March 1, 2018.